New understanding of biomarkers could lead to earlier diagnosis of fatal diseases
A new research paper sheds light on the way antibodies distinguish between different but closely related “biomarkers” — proteins which reveal information about the condition of the human body. This new understanding could enable pharmaceutical companies to develop new technologies for quickly diagnosing and treating fatal diseases.